Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Tonix Pharmaceuticals Holding Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Oct 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Tonix Pharmaceuticals Holding Corp (TNXP-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 Nov 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for TNXP

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

30 Oct 2016 ValuEngine, Inc. 11 $25.00

Value Graph: TONIX PHARMACEUT -- TNXP

28 Oct 2016 Ford Investor Services, Inc. 1 $12.00

Tonix Pharmaceuticals Holding Corp. (TNXP) - Financial Analysis Review

Tonix Pharmaceuticals Holding Corp. (TNXP) - Financial Analysis Review Summary Tonix Pharmaceuticals Holding Corp. (Tonix), f...

17 Oct 2016 GlobalData 58 $300.00

TONIX PHARMACEUTICALS HOLDING CP (TNXP=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

08 Oct 2016 Pechala's Reports 2 $25.00

Tonix Pharmaceuticals - Fibromyalgia setback, focus on PTSD

Tonix reported that the Phase III trial of TNX-102 SL for the treatment of fibromyalgia did not reach its primary endpoint of...

03 Oct 2016 Edison Investment Research 8 $10.00

Tonix Pharmaceuticals Holding Corp. (TNXP) - Financial Analysis Review

Tonix Pharmaceuticals Holding Corp. (TNXP) - Financial Analysis Review Summary Tonix Pharmaceuticals Holding Corp. (Tonix), f...

13 Sep 2016 GlobalData 50 $300.00

Tonix Pharmaceuticals Holding Corp. (TNXP) - Financial Analysis Review

Tonix Pharmaceuticals Holding Corp. (TNXP) - Financial Analysis Review Summary Tonix Pharmaceuticals Holding Corp. (TONIX) is...

15 Jun 2016 GlobalData 50 $300.00

TONIX PHARMACEUTICALS - PHASE II SUCCESS IN MILITARY-RELATED PTSD

Tonix reported positive Phase II results for TNX-102 SL (sublingual formulation of cyclobenzaprine) marking the first-ever la...

25 May 2016 Edison Investment Research 6 $10.00